An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 050740
Company: ASTELLAS

Products on NDA 050740

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
AMBISOME	AMPHOTERICIN B	50MG/VIAL	INJECTABLE, LIPOSOMAL;INJECTION	Prescription	AB	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 050740

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/11/1997	ORIG-1	Approval	Type 2 - New Active Ingredient	PRIORITY; Orphan	Review	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/nda/97/050740_ambisome_toc.html

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/04/2024	SUPPL-37	Labeling-Container/Carton Labels, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/050740Orig1s037Lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/050740Orig1s37ltr.pdf
02/04/2021	SUPPL-33	Labeling-Container/Carton Labels, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050740Orig1s033lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/050740Orig1s033ltr.pdf
05/12/2020	SUPPL-31	Labeling-Package Insert, Labeling-Container/Carton Labels	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050740Orig1s031lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/050740Orig1s031ltr.pdf
09/16/2014	SUPPL-23	Manufacturing (CMC)		Label is not available on this site.
03/08/2012	SUPPL-21	Labeling-Package Insert	Label (PDF) Letter (PDF)	Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050740s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/050740s021ltr.pdf
10/08/2008	SUPPL-16	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050740s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/050740s016ltr.pdf
09/16/2003	SUPPL-14	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/50740slr014_ambisome_lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/50740slr014ltr.pdf
09/06/2002	SUPPL-12	Manufacturing (CMC)-Control		Label is not available on this site.
06/14/2002	SUPPL-11	Manufacturing (CMC)		Label is not available on this site.
03/27/2002	SUPPL-10	Manufacturing (CMC)-Control		Label is not available on this site.
03/06/2002	SUPPL-9	Manufacturing (CMC)		Label is not available on this site.
12/04/2001	SUPPL-8	Manufacturing (CMC)-Control		Label is not available on this site.
05/11/2001	SUPPL-7	Manufacturing (CMC)-Control		Label is not available on this site.
07/13/2000	SUPPL-6	Manufacturing (CMC)-Packaging		Label is not available on this site.
06/26/2000	SUPPL-5	Manufacturing (CMC)		Label is not available on this site.
02/29/2000	SUPPL-4	Manufacturing (CMC)		Label is not available on this site.
03/16/2000	SUPPL-3	Manufacturing (CMC)		Label is not available on this site.
06/16/2000	SUPPL-2	Efficacy-New Indication	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/50740S2LBL.PDF https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/50740S2LTR.PDF https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/50-740S2_AmBisome.html
01/28/2000	SUPPL-1	Efficacy-Labeling Change With Clinical Data	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/50-740S001_AmBisome_prntlbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/50-740S001_AmBisome_Approv.pdf https://www.accessdata.fda.gov/drugsatfda_docs/anda/2000/050740s001_ambisome_toc.html

Labels for NDA 050740

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/04/2024	SUPPL-37	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/050740Orig1s037Lbl.pdf
11/04/2024	SUPPL-37	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/050740Orig1s037Lbl.pdf
02/04/2021	SUPPL-33	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050740Orig1s033lbl.pdf
02/04/2021	SUPPL-33	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050740Orig1s033lbl.pdf
05/12/2020	SUPPL-31	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050740Orig1s031lbl.pdf
05/12/2020	SUPPL-31	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050740Orig1s031lbl.pdf
03/08/2012	SUPPL-21	Labeling-Package Insert	Label (PDF)	Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050740s021lbl.pdf
10/08/2008	SUPPL-16	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050740s016lbl.pdf
09/16/2003	SUPPL-14	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/50740slr014_ambisome_lbl.pdf
06/16/2000	SUPPL-2	Efficacy-New Indication	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/50740S2LBL.PDF
01/28/2000	SUPPL-1	Efficacy-Labeling Change With Clinical Data	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/50-740S001_AmBisome_prntlbl.pdf

Therapeutic Equivalents for NDA 050740

AMBISOME

INJECTABLE, LIPOSOMAL;INJECTION; 50MG/VIAL
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
AMBISOME	AMPHOTERICIN B	50MG/VIAL	INJECTABLE, LIPOSOMAL;INJECTION	Prescription	Yes	AB	050740	ASTELLAS
AMPHOTERICIN B	AMPHOTERICIN B	50MG/VIAL	INJECTABLE, LIPOSOMAL;INJECTION	Prescription	No	AB	215354	AVET LIFESCIENCES
AMPHOTERICIN B	AMPHOTERICIN B	50MG/VIAL	INJECTABLE, LIPOSOMAL;INJECTION	Prescription	No	AB	214010	EUGIA PHARMA
AMPHOTERICIN B	AMPHOTERICIN B	50MG/VIAL	INJECTABLE, LIPOSOMAL;INJECTION	Prescription	No	AB	212967	MYLAN LABS LTD
AMPHOTERICIN B	AMPHOTERICIN B	50MG/VIAL	INJECTABLE, LIPOSOMAL;INJECTION	Prescription	No	AB	212514	SPIL

Top